Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus

BACKGROUND: This study was performed to satisfy a US Food and Drug Administration post-marketing requirement to compare the dose responses for Technosphere(®) Insulin (TI; MannKind Corporation, Westlake Village, CA, USA) and subcutaneous insulin lispro (LIS) across a wide range of doses. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Marshall, Heise, Tim, Baughman, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891188/
https://www.ncbi.nlm.nih.gov/pubmed/34773608
http://dx.doi.org/10.1007/s40262-021-01084-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891188/
https://www.ncbi.nlm.nih.gov/pubmed/34773608
http://dx.doi.org/10.1007/s40262-021-01084-0

Ejemplares similares